| Year |
Citation |
Score |
| 2024 |
Ralph LT, Georgiou J, Collingridge GL, Tidball P. Sex-dependence of synaptic depression induced by activation of metabotropic glutamate receptors in rat hippocampus. Brain and Neuroscience Advances. 8: 23982128231223579. PMID 38298523 DOI: 10.1177/23982128231223579 |
0.714 |
|
| 2020 |
Kang H, Park P, Han M, Tidball P, Georgiou J, Bortolotto ZA, Lodge D, Kaang BK, Collingridge GL. (2,6)- and (2,6)-hydroxynorketamine inhibit the induction of NMDA receptor-dependent LTP at hippocampal CA1 synapses in mice. Brain and Neuroscience Advances. 4: 2398212820957847. PMID 33088919 DOI: 10.1177/2398212820957847 |
0.744 |
|
| 2019 |
Sanderson TM, Georgiou J, Tidball P, Collingridge GL. The Hippocampus Is the Place to Be: Opioid Receptors and LTP. Cell Reports. 28: 1117-1118. PMID 31365856 DOI: 10.1016/J.Celrep.2019.07.051 |
0.753 |
|
| 2017 |
Tidball P, Burn HV, Teh KL, Volianskis A, Collingridge GL, Fitzjohn SM. Differential ability of the dorsal and ventral rat hippocampus to exhibit group I metabotropic glutamate receptor-dependent synaptic and intrinsic plasticity. Brain and Neuroscience Advances. 1. PMID 28413831 DOI: 10.1177/2398212816689792 |
0.681 |
|
| 2013 |
Lodge D, Tidball P, Mercier MS, Lucas SJ, Hanna L, Ceolin L, Kritikos M, Fitzjohn SM, Sherwood JL, Bannister N, Volianskis A, Jane DE, Bortolotto ZA, Collingridge GL. Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptors. Neuropharmacology. 74: 135-46. PMID 23542080 DOI: 10.1016/J.Neuropharm.2013.03.011 |
0.538 |
|
| 2013 |
Collingridge GL, Volianskis A, Bannister N, France G, Hanna L, Mercier M, Tidball P, Fang G, Irvine MW, Costa BM, Monaghan DT, Bortolotto ZA, Molnár E, Lodge D, Jane DE. The NMDA receptor as a target for cognitive enhancement. Neuropharmacology. 64: 13-26. PMID 22796429 DOI: 10.1016/J.Neuropharm.2012.06.051 |
0.73 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1981 |
Tidball P. The pharmaceutical industry's responsibilities in the prescription process. Canadian Pharmaceutical Journal. 114: 177-9. PMID 10251274 |
0.041 |
|
| 1982 |
Tidball P. Capitation payment for pharmacy: a head start on fair return? Canadian Pharmaceutical Journal. 115: 271-3. PMID 10256465 |
0.039 |
|
| 1984 |
Tidball P. Problems in designing a government drug payment program in Canada. Cpj : Canadian Pharmaceutical Journal = Rpc : La Revue Pharmaceutique Canadienne. 117: 468-71, 477. PMID 10268503 |
0.024 |
|
| 1980 |
Tidball P. Reduced prescription size: a question of health care or money? The answer is money, say drug plans. Canadian Pharmaceutical Journal. 113: 165-6. PMID 10249549 |
0.013 |
|
| 1980 |
Tidball P. BC's Pharmacare speaks out. Canadian Pharmaceutical Journal. 113: 305-6, 316. PMID 10249552 |
0.01 |
|
| Hide low-probability matches. |